FONAR Corporation logo
FONAR Corporation FONR
$ 18.41 0.38%

Quarterly report 2025-Q4
added 02-13-2026

report update icon

FONAR Corporation Net Income 2011-2026 | FONR

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income FONAR Corporation

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
12.4 M 10.2 M 8.24 M 15.3 M 21.2 M 19.6 M 15.7 M 12.9 M 10.4 M 8.68 M 5.78 M 3.16 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
21.2 M 3.16 M 12 M

Quarterly Net Income FONAR Corporation

2025-Q4 2025-Q3 2025-Q1 2024-Q4 2024-Q3 2024-Q1 2023-Q4 2023-Q3 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
2.06 M 2.26 M 2.51 M 1.96 M 3.14 M 1.87 M 3.76 M 4.11 M 3.86 M 2.23 M 2.05 M 4.28 M 2.29 M 4.02 M 3.89 M 7.91 M 3.87 M 3.11 M 2.51 M 3.11 M 2.51 M 3.1 M 3.3 M 3.1 M 3.3 M 3.55 M 3.32 M 3.55 M 3.32 M 4.19 M 3.72 M 4.19 M 3.72 M 4.24 M 3.57 M 4.24 M 3.57 M 3.49 M 2.86 M 3.49 M 2.86 M 2.66 M 2.54 M 2.66 M 2.54 M 2.14 M 2.44 M 2.14 M 2.44 M 1.35 M 1.45 M 1.35 M 1.45 M 1.54 M 1.51 M 1.54 M 1.51 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
7.91 M 1.35 M 2.97 M

References

  1. Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Medical devices industry

Issuer Net Income Price % 24h Market Cap Country
Delcath Systems Delcath Systems
DCTH
2.7 M $ 8.98 -1.32 % $ 322 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
-18.6 M - - $ 1.77 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
-59.7 M - - $ 3.31 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
53.4 M - 1.37 % $ 20.5 M usaUSA
Acutus Medical Acutus Medical
AFIB
-81.7 M - -26.83 % $ 2.62 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
-1.94 M - 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
-12.3 M - -5.86 % $ 30.6 M usaUSA
Inogen Inogen
INGN
-22.7 M $ 6.32 -2.02 % $ 168 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
22.5 M $ 100.97 1.78 % $ 1.28 B usaUSA
BioSig Technologies BioSig Technologies
BSGM
-10.3 M - 37.08 % $ 85.7 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
-242 M $ 62.4 -1.33 % $ 3.4 B britainBritain
Medtronic PLC Medtronic PLC
MDT
4.66 B $ 86.58 -0.68 % $ 111 B usaUSA
Conformis Conformis
CFMS
-50.5 M - - $ 16.4 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
-92.2 M $ 11.72 -1.26 % $ 464 M curacaoCuracao
Cardiovascular Systems Cardiovascular Systems
CSII
-36.9 M - 0.15 % $ 844 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
-9.57 M $ 1.35 - $ 21.8 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
-39.8 M - - $ 475 M usaUSA
Penumbra Penumbra
PEN
178 M $ 334.17 -0.41 % $ 13 B usaUSA
LENSAR LENSAR
LNSR
-31.4 M $ 5.56 -8.4 % $ 64 M usaUSA
Avinger Avinger
AVGR
-18.3 M - -20.74 % $ 369 K usaUSA
Insulet Corporation Insulet Corporation
PODD
247 M $ 225.5 -0.7 % $ 15.9 B usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
-16.7 M - -4.14 % $ 702 M usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
-30.7 M $ 5.15 -4.63 % $ 180 M canadaCanada
Quanterix Corporation Quanterix Corporation
QTRX
-107 M $ 3.82 -3.05 % $ 163 M usaUSA
AxoGen AxoGen
AXGN
-15.7 M $ 32.61 2.71 % $ 1.5 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
47.1 M $ 36.56 -0.19 % $ 1.13 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
-14.5 M - -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
-9.14 K - -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
-10.9 M - 0.03 % $ 1.58 B israelIsrael
Electromed Electromed
ELMD
7.54 M $ 24.7 0.86 % $ 209 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
-17.4 M - - $ 462 M usaUSA
Neovasc Neovasc
NVCN
-24.9 M - - $ 111 M canadaCanada
Sintx Technologies Sintx Technologies
SINT
-10.4 M $ 2.57 0.78 % $ 7.13 M usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
-7.72 M $ 3.96 -3.65 % $ 64.7 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
-72.3 M - - $ 955 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
-20.7 M $ 0.7 3.3 % $ 38.1 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
-13.4 M $ 2.16 -6.09 % $ 3.37 M usaUSA
Stryker Corporation Stryker Corporation
SYK
849 M $ 328.51 -1.23 % $ 126 B usaUSA
BIOLASE BIOLASE
BIOL
-20.6 M - -13.19 % $ 166 K usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
-70.8 M $ 11.48 10.7 % $ 1.55 B usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
-589 K $ 24.51 -2.31 % $ 1.67 B usaUSA
Myomo Myomo
MYO
-15.6 M $ 0.7 -1.83 % $ 29.3 M usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
-53.5 M $ 2.4 -1.64 % $ 141 M israelIsrael
Invacare Corporation Invacare Corporation
IVC
-20.6 M - - $ 24.7 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
-19 M $ 3.91 4.83 % $ 146 M franceFrance
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
-39.6 M $ 15.91 -3.4 % $ 373 M usaUSA
Outset Medical Outset Medical
OM
-81.7 M $ 3.53 -2.35 % $ 53.7 K usaUSA